CompletedPHASE2, PHASE3NCT05031143
Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment
Studying Vogt-Koyanagi-Harada disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Benha University
- Principal Investigator
- Ahmed Abdelshafy, MDBenha University, faculty of medicine
- Intervention
- Suprachoroidal Triamcinolone acetonide injection for serous retinal detachment in VKH disease(drug)
- Enrollment
- 6 enrolled
- Eligibility
- 47-52 years · All sexes
- Timeline
- 2020 – 2021
Study locations (1)
- Ophthalmology department,Benha University and Ebsar eye center,Benha,EGYPT, Banhā, Qualiobeya, Egypt
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05031143 on ClinicalTrials.govOther trials for Vogt-Koyanagi-Harada disease
Additional recruiting or active studies for the same condition.